M&A Deal Summary |
|
|---|---|
| Date | 2008-06-04 |
| Target | Protez Pharmaceuticals |
| Sector | Life Science |
| Buyer(s) | Novartis |
| Sellers(s) |
Easton Capital Investment Group
L Capital Partners Bay City Capital |
| Deal Type | Add-on Acquisition |
| Deal Value | 400M USD |
| Advisor(s) | Duane Morris Potter Anderson & Corroon (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1996 |
| Sector | Life Science |
| Employees | 104,323 |
| Revenue | 46.7B USD (2023) |
Novartis is a global healthcare and pharmaceutical enterprise dedicated to advancing medical innovation and enhancing patient well-being. Renowned for its pioneering research and development efforts, Novartis has a comprehensive portfolio encompassing groundbreaking pharmaceuticals, generic medications, biosimilars, and eye care solutions. Novartis was founded in 1996 and is based in Basel, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 32 |
| Sector (Life Science) | 3 of 26 |
| Type (Add-on Acquisition) | 3 of 28 |
| State (Pennsylvania) | 1 of 1 |
| Country (United States) | 3 of 24 |
| Year (2008) | 1 of 1 |
| Size (of disclosed) | 12 of 17 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-04-20 |
Chiron
Emeryville, California, United States Chiron Corporation was a multinational biotechnology firm based in Emeryville, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-08-28 |
HySolv Technology
United States HySolv™ was developed by Protherics Salt Lake City Inc. (formerly MacroMed, Inc.) from a patented solvent technology platform for solubilising hydrophobic drugs in a hydrophilic environment. |
Buy | $10M |
| Category | Venture Capital Firm |
|---|---|
| Founded | 2000 |
| PE ASSETS | 200M USD |
| Size | Small |
| Type | Sector Focused |
Easton Capital Investment Group is a private investment firm that targets early-stage venture capital to later-stage growth capital investments. Easton will consider opportunities across a range of industries but generally invests in the healthcare industry, including biopharmaceuticals, drug delivery, medical devices, and healthcare services. Easton looks to commit $0.50 to $10 million per transaction. Easton Capital was formed in 2000 and is based in New York.
| DEAL STATS | # |
|---|---|
| Overall | 11 of 20 |
| Sector (Life Science) | 5 of 10 |
| Type (Add-on Acquisition) | 5 of 9 |
| State (Pennsylvania) | 1 of 1 |
| Country (United States) | 11 of 20 |
| Year (2008) | 1 of 2 |
| Size (of disclosed) | 3 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-01-01 |
Autonet Mobile
Santa Rosa, California, United States Autonet Mobile is a mobile internet service provider. Autonet Mobile has created a mobile internet connectivity solution for cars by providing broadband service and always-on WiFi connectivity nationwide. Autonet Mobile was founded in 2005 and is based in Santa Rosa, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-08-01 |
Lamina Ceramics
Westampton, New Jersey, United States Lamina defines the state of technology in the development and manufacture of super-bright LED light engines. The Company's leading edge LED packaging technology and design, and its proprietary multi-layer ceramic on metal packaging solution provides unsurpassed thermal management and interconnectivity. Lamina's technology emerged from 12 years of research and development at the Sarnoff Corporation - the same laboratory that developed such world-changing inventions as: color television, the liquid crystal display technology that is used in cell phones, laptops and watches, and today's High Definition Television and satellite TV technology. Easton led an investment in Lamina in April 2007. Other investors in the Company include Morgenthaler Ventures, Sarnoff Corporation, RedShift Ventures, Granite Global, CID Capital, Kemet Electronics Corporation and Richard King Mellon Foundation. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2004 |
| PE ASSETS | 165M USD |
| Size | Small |
| Type | Sector Focused |
L Capital Partners is a specialist private equity firm focused on investing in companies operating within the healthcare, technology, and energy/environmental sectors, looking to bring 'groundbreaking products to market'. Within healthcare, L Capital looks to invest in biopharmaceutical and medical device businesses. Within technology, the Firm's emphasis is on security/defense and IT businesses. And within the energy/environmental sector, the L Capital's focus is investing in opportunities that 'improve the quality of life'. L Capital was formed in 2004 and has offices in New York City and Tel Aviv, Israel.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 7 |
| Sector (Life Science) | 1 of 2 |
| Type (Add-on Acquisition) | 1 of 5 |
| State (Pennsylvania) | 1 of 1 |
| Country (United States) | 2 of 7 |
| Year (2008) | 1 of 1 |
| Size (of disclosed) | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-12-12 |
ProRhythm
Ronkonkoma, New York, United States ProRhythm, Inc. engages in the development and manufacture of medical devices for the treatment of Atrial Fibrillation (AF). It develops High Intensity Focused Ultrasound (HIFU) applications to advance the minimally invasive treatment of complex medical conditions. ProRhythm's catheter-based system uses HIFU to treat AF in part by the electrical isolation of the pulmonary veins and ablation within the left atrium of the heart. Its products are currently used in Europe and the United States. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-06-23 |
Simparel
New York, New York, United States Software company delivering new generation of ERP solutions and Software as a Service (SaaS). Providing the simplest, most flexible and affordable global supply chain business solution available today. |
Buy | $4M |
| Category | Venture Capital Firm |
|---|---|
| Founded | 1997 |
| PE ASSETS | 1.3B USD |
| Size | Large |
| Type | Sector Focused |
Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 26 of 62 |
| Sector (Life Science) | 17 of 45 |
| Type (Add-on Acquisition) | 13 of 31 |
| State (Pennsylvania) | 1 of 2 |
| Country (United States) | 24 of 59 |
| Year (2008) | 1 of 3 |
| Size (of disclosed) | 5 of 18 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-04-02 |
ProGenTech USA
Emeryville, California, United States Molecular diagnostics device company developing automated instruments for nucleic acid purification (NAP) and nucleic acid testing (NAT). The company's first fully-integrated NAP system, the PGT 328, increases the efficiency and quality of nucleic acid purification using ProGenTech's uniquely designed disposable cartridges. |
Buy | $21M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-08-01 |
Synchronicity Pharma
San Jose, California, United States Synchronicity Pharma is a developer of cryptochrome (Cry) modulators for treating metabolic disorders by restoring rhythmsmodulators. Synchronicity Pharma was founded in 2008 and is based in San Jose, California. |
Buy | - |
